10Clines GA,Guise TA.Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to boneEndocrine Related Cancer,2005.
8Grill V, Martin T J. Hypercalcemia of malignancy[J].Rev Endoer Metab Disord, 2000,1 (4) : 253 -263.
9Body J J, Bartl R, Burekhardt P, et al. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group[J].J ClinOncol,1998,16(9):3890 -3899.
10Body J J. Hypercalcemia of malignancy[J]. Semin Nephrol, 2004, 24(1) :48-54.
2Ijaz A, Mehmood T, Qureshi AH, et al. Estimation of ionized calci- um, total calcium and albumin con'ected calcimn for the diagnosis of hypercalcaemia of malignancy [ J ]. J Coll Physicians Surg Pak, 2006,16 ( 1 ) :49 - 52.
3Gaga M,Powell C,Schraufnagel D,et al. An official American Thoracic Society/European Respiratory Society statement. the role of the pulmonologist in the diagnosis and management of lung cancer[J]. Am J Respir Crit Care Med, 2013, 188(4):503-507.
5Früh M,De Ruysscher D,Popa Se,et al. Small-cell lung cancer (SCLC):ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2013,24(Suppl 6):vi99-vi105.
6Pelosof LC,Gerber DE. Paraneoplastic syndromes:an approach to diagnosis and treatment[J]. Mayo Clin Proc, 2010, 85(9):838-854.
7Karim AR,Jacob S.Immunological markers in neurological disorders[J].Ann Clin Biochem,2012,49(Pt 1):29-43.
8Inuzuka T, Hayashi Y, Kimura A.Pareneoplastic neurological syndrome-update[J].Rinsho Shinkeigaku,2011,51(11):834-837.
9Vedeler CA, Antoine JC, Giometto B, et al. Paraneoplastic neurological syndromes[M].2nd ed. Wiley:European Handbook of Neurological Management,2011:447-457.
10Dalmau J, Rosenfeld MR. Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia.www.uptodate.com (accessed December 2014).
